Medicare Enrolled

Dr. Irfan Jawed, MD

Medical Oncology · Houston, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
13310 BEAMER RD STE B, Houston, TX 77089
8328792942
In practice since 2008 (17 years)
NPI: 1356508501 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jawed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jawed? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jawed

Dr. Irfan Jawed is a medical oncology in Houston, TX, with 17 years in practice. Based on federal Medicare data, Dr. Jawed performed 2,813 Medicare services across 918 unique beneficiaries.

Between the years covered by Open Payments, Dr. Jawed received a total of $31,359 from 60 pharmaceutical and/or device companies across 364 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jawed is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 46% volume in TX$ $31,359 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,813
Medicare services
Top 46% in TX for medical oncology
918
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~165 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity1,012$96$160
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg440$2$24
Initial hospital admission, high complexity213$139$360
Advance care planning, each additional 30 minutes177$58$140
Advance care planning consultation, first 30 min176$61$120
Hospital follow-up visit, moderate complexity174$64$159
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less138$23$80
Office visit, established patient (30-39 min)132$99$199
Infusion, normal saline solution, 250 cc100$1$25
Injection, diphenhydramine hcl, up to 50 mg95$1$5
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour62$16$55
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less61$50$150
Office visit, established patient (20-29 min)33$72$215
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.8% high complexity
19.0% medium
68.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$31,359
Total received (2018-2024)
Avg $4,480/year across 7 years
Top 26% in TX for medical oncology
60
Companies
364
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$18,768 (59.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,364 (20.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,228 (19.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,138
2023
$567
2022
$1,113
2021
$986
2020
$897
2019
$7,120
2018
$19,538

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
INSYS Therapeutics Inc
$18,618
E.R. Squibb & Sons, L.L.C.
$4,105
AstraZeneca Pharmaceuticals LP
$3,061
Novartis Pharmaceuticals Corporation
$709
Boehringer Ingelheim Pharmaceuticals, Inc.
$363
Amgen Inc.
$350
PFIZER INC.
$284
Eisai Inc.
$251
SOBI, INC
$230
Janssen Pharmaceuticals, Inc
$217
Daiichi Sankyo Inc.
$193
Merck Sharp & Dohme Corporation
$180
AVEO Pharmaceuticals, Inc.
$172
Celgene Corporation
$158
Merck Sharp & Dohme LLC
$150
Janssen Biotech, Inc.
$148
Incyte Corporation
$146
Exelixis Inc.
$137
PharmaEssentia USA Corporation
$125
Ipsen Biopharmaceuticals, Inc
$120
Gilead Sciences, Inc.
$95
Kite Pharma, Inc.
$90
Alexion Pharmaceuticals, Inc.
$89
Pharmacosmos Therapeutics Inc.
$86
GlaxoSmithKline, LLC.
$85
Aveo Pharmaceuticals, Inc.
$80
TAIHO ONCOLOGY, INC.
$77
Dova Pharmaceuticals
$76
CTI BioPharma Corp.
$73
EMD Serono, Inc.
$71
TerSera Therapeutics LLC
$70
Bayer HealthCare Pharmaceuticals Inc.
$62
Taiho Oncology, Inc.
$55
Genentech USA, Inc.
$53
Takeda Pharmaceuticals U.S.A., Inc.
$49
Seattle Genetics, Inc.
$46
Lilly USA, LLC
$40
Teva Pharmaceuticals USA, Inc.
$32
Apellis Pharmaceuticals, Inc.
$30
Blueprint Medicines Corporation
$27
ABBVIE INC.
$27
Nestle HealthCare Nutrition Inc.
$27
Pharmacyclics LLC, an AbbVie Company
$23
Shield Therapeutics Inc
$23
Deciphera Pharmaceuticals Inc.
$22
SpringWorks Therapeutics, Inc.
$20
Azurity Pharmaceuticals, Inc.
$19
GENZYME CORPORATION
$19
Sobi, Inc
$18
West Therapeutics Development, LLC
$17
MorphoSys, US Inc.
$16
Rigel Pharmaceuticals, Inc.
$16
Kyowa Kirin, Inc.
$15
Pharmacyclics LLC, An AbbVie Company
$15
Heron Therapeutics, Inc.
$15
Spectrum Pharmaceuticals Inc.
$14
ARRAY BIOPHARMA INC
$13
Foundation Medicine, Inc.
$13
IBSA Pharma Inc.
$12
TESARO, Inc.
$12
Top 3 companies account for 82.2% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADAKVEO · ADCETRIS · AFINITOR · Abraxane · Alecensa · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · Bavencio · Blincyto · CINVANTI · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ENHERTU · ERBITUX · Empaveli · Enhertu · Erleada · FOTIVDA · FOUNDATIONONE · Fabhalta · GAVRETO · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LONSURF · LUMAKRAS · LYNPARZA · Lazanda · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · Monoferric · Nexavar · Nplate · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · PROMACTA · Pomalyst · QINLOCK · Quzyttir · REBLOZYL · ROLVEDON · Rezlidhia · SANCUSO · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNAGIS · SYNDROS · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · Tirosint · Trodelvy · Truxima · ULTOMIRIS · VIVIMUSTA · VONJO · VOTRIENT · Vonjo · XALKORI · XARELTO · XGEVA · Xermelo · Yescarta · ZEJULA · ZENPEP · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (60%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $1,115 per 100 Medicare services performed
Looking for a medical oncology in Houston?
Compare medical oncologys in the Houston area by procedure volume, costs, and industry payment transparency.
Browse medical oncologys nearby

Geographic Context

Medical Oncologys within 10 mi
179
Per 100K population
3.8
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE SOUTHEAST
4.7 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Jawed is a mixed practice specialist, with moderate Medicare volume, and speaking/promotional industry engagement, with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Jawed experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Jawed performed 1,012 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jawed receive payments from pharmaceutical companies?
Yes. Dr. Jawed received a total of $31,359 from 60 companies across 364 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jawed's costs compare to other medical oncologys in Houston?
Dr. Jawed's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jawed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →